Pharmanet in distribution agreement with MPL USA
Sydney - Thursday - October 13: (RWE Aust Business News) -
Pharmanet Group Ltd's (ASX:PNO) subsidiary Molecular Pharmacology Ltd (MPL) has entered into a distribution and supply agreement with Molecular Pharmacology (USA) Ltd (MPL USA).
MPL USA is granted the exclusive right to distribute, market, promote and/or sell topical therapeutic products for analgesic and anti-inflammatory use in humans in the USA.
It will be able to utilise the MPL trademarks and tradenames associated with the licenced product.
MPL currently holds the licensing rights from Cambridge Scientific Pty Ltd, a wholly owned subsidiary of the company and the holder of the intellectual property.